ADGRE2 and immune system disorder: The tissue expression and biology of EMR2 and CD97 suggest possible roles in inflammatory/immune disorders, and a key question is whether modulation of their G protein signalling could provide a tractable therapeutic opportunity, as precedented for medicines that act on Family A GPCRs.